2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related compounds elicit a broad spectrum of species and tissue-specific toxic and biologic effects in laboratory animals and mammalian cells in culture. We have recently shown that 6-methyl-1,3,8-trichlorodibenzofuran (MCDF) antagonizes the effects of TCDD and this project will probe the mechanism of this process. MCDF, like some hormone antagonists, may act, in part, by modulating nuclear and/or cytosolic Ah receptor levels. Therefore, the proposed studies (experiment I) will investigate the effects of MCDF on the levels of nuclear [3H]-TCDD-Ah receptor complex, the stability and rate of processing of the nuclear receptor complex and the effects of MCDF on the rate of replenishment of cytosolic Ah receptor. Both of the studies will be carried out using ED80-100 doses of TCDD (for AHH induction) and the maximum inhibitory levels of MCDF in male Long Evans rats and rat hepatoma H-4-II E cells in culture). It is proposed that the observed decrease in the inductions of AHH (by TCDD) is associated with a concurrent decrease in TCDD-induced transcription. Therefore, experiment 2 will determine the effects of MCDF on TCDD- induced transcription of cytochrome p-4501A1 and P-4501A2 mRNAs is male rats and cytochrome P-4501A1 mRNA in rate hepatoma H-4-II E cells using cDNA probes which are available in this laboratory. Preliminary studies have demonstrated that the 8-iodo analog of MCDF (i.e., I-MCDF) exhibits comparable properties as a TCDD antagonist. Experiment 3 will fully characterize the activity of I-MCDF as an antagonist of the induction of the transcription and translation of the cytochrome P-4501A1 and P-4501A2 genes by TCDD. The second phase of this study will (a) determine the molecular properties of the 125I-MCDF- Ah receptor complex and utilize the radiolabled antagonist to detect the formation of nuclear antagonist receptor complexes. The final study will more fully investigate the molecular mechanism of action of TCDD antagonists using the plasmid pMcat5.12 which contains a chloramphenicol acetyl transferase (CAT) gene, the MMTV promoter and an 82 bp fragment designated DRE 3 (dioxin regulatory element). Following transfection into Hepa 1c1c7 cells, the effect of TCDD, MCDF and TCDD plus MCDF on transcriptional activation will be determined. The effects of MCDF on the interaction of the TCDD-Ah receptor complex with DRE 3 and the direct interaction of 125I-MCDF-receptor complexes with this proposed nuclear binding site will be determined by gel retardation assays using the appropriate nuclear extracts, the 82 bp polynucleotide fragment and 32P-labeled DNA and 125I-labeled agonist or antagonist. These proposed studies are designed to delineate the mechanisms of action associated with the antagonism of the induction of cytochrome P-450 gene transcription by TCDD.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES003843-07
Application #
3251583
Study Section
Toxicology Subcommittee 2 (TOX)
Project Start
1986-07-01
Project End
1993-06-30
Budget Start
1992-07-01
Budget End
1993-06-30
Support Year
7
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Texas A&M University
Department
Type
Schools of Veterinary Medicine
DUNS #
City
College Station
State
TX
Country
United States
Zip Code
77845
Hoivik, D; Willett, K; Wilson, C et al. (1997) Estrogen does not inhibit 2,3,7, 8-tetrachlorodibenzo-p-dioxin-mediated effects in MCF-7 and Hepa 1c1c7 cells. J Biol Chem 272:30270-4
Wilson, C L; Thomsen, J; Hoivik, D J et al. (1997) Aryl hydrocarbon (Ah) nonresponsiveness in estrogen receptor-negative MDA-MB-231 cells is associated with expression of a variant arnt protein. Arch Biochem Biophys 346:65-73
Hoivik, D; Wilson, C; Wang, W et al. (1997) Studies on the relationship between estrogen receptor content, glutathione S-transferase pi expression, and induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin and drug resistance in human breast cancer cells. Arch Biochem Biophys 348:174-82
Lu, Y F; Santostefano, M; Cunningham, B D et al. (1996) Substituted flavones as aryl hydrocarbon (Ah) receptor agonists and antagonists. Biochem Pharmacol 51:1077-87
Santostefano, M; Safe, S (1996) Characterization of the molecular and structural properties of the transformed and nuclear aryl hydrocarbon (Ah) receptor complexes by proteolytic digestion. Chem Biol Interact 100:221-40
Wang, W L; Thomsen, J S; Porter, W et al. (1996) Effect of transient expression of the oestrogen receptor on constitutive and inducible CYP1A1 in Hs578T human breast cancer cells. Br J Cancer 73:316-22
Wang, X; Thomsen, J S; Santostefano, M et al. (1995) Comparative properties of the nuclear aryl hydrocarbon (Ah) receptor complex from several human cell lines. Eur J Pharmacol 293:191-205
Lu, Y F; Santostefano, M; Cunningham, B D et al. (1995) Identification of 3'-methoxy-4'-nitroflavone as a pure aryl hydrocarbon (Ah) receptor antagonist and evidence for more than one form of the nuclear Ah receptor in MCF-7 human breast cancer cells. Arch Biochem Biophys 316:470-7
Merchant, M; Safe, S (1995) In vitro inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced activity by alpha-naphthoflavone and 6-methyl-1,3,8-trichlorodibenzofuran using an aryl hydrocarbon (Ah)-responsive construct. Biochem Pharmacol 50:663-8
Moore, M; Wang, X; Lu, Y F et al. (1994) Benzo[a]pyrene-resistant MCF-7 human breast cancer cells. A unique aryl hydrocarbon-nonresponsive clone. J Biol Chem 269:11751-9

Showing the most recent 10 out of 39 publications